Nausea
📧 Sign up to get email alerts when something new happens for Nausea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-07-29Clinical Trial Update: Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT [Phase 4]
A Phase 4 randomized trial comparing haloperidol with diphenhydramine versus metoclopramide with diphenhydramine for acute headaches (migrai…
-
EMA withdrawal · 2022-04-08EMA Withdrawn: Palonosetron Hospira (palonosetron hydrochloride) — Pfizer Europe MA EEIG
Palonosetron Hospira (palonosetron hydrochloride) has been withdrawn in the EMA system.
-
EMA withdrawal · 2020-03-02EMA Withdrawn: Varuby (rolapitant) — TESARO Bio Netherlands B.V.
EMA has withdrawn Varuby (rolapitant) from the market in the Netherlands/EMA record; the withdrawal concerns vomiting, nausea, and cancer in…
-
CLINICAL_TRIALS withdrawal · 2016-03-17Clinical Trial Update: Evidence of Haloperidol Absorption After Topical Administration [EARLY_Phase 1]
An early Phase 1 trial evaluating the absorption of topical haloperidol for nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.